NASDAQ: SURG
SurgePays, Inc.CIK 0001392694 · SIC 4813 · Telephone Communications
Small
Revenue $57M
Assets $9M
as of Aug 26, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.
10-Q
Filed Aug 19, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
8-K
Filed Aug 5, 2026
· Period ending Aug 3, 2026
Summary not yet generated.
Partner
Trade SURG commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Jul 29, 2026
· Period ending Jul 28, 2026
Summary not yet generated.
8-K
Filed Jul 1, 2026
· Period ending Jun 29, 2026
Summary not yet generated.
8-K
Filed Jun 22, 2026
· Period ending Jun 16, 2026
Summary not yet generated.
8-K
Filed Jun 22, 2026
· Period ending Jun 16, 2026
Summary not yet generated.
10-Q
Filed May 20, 2026
· Period ending Mar 31, 2026
Red flag
Revenue up 51% but gross margin collapses to -48%; working capital deficit doubles to $16.0M
5 material changes detected. Sign up free to read the summary.
8-K
Filed May 20, 2026
· Period ending May 15, 2026
SurgePays reports Q1 2026 financial results, holds earnings call
2 material changes detected. Sign up free to read the summary.
8-K
Filed Apr 16, 2026
· Period ending Apr 14, 2026
SurgePays reports 2025 full-year financial results in April 2026 earnings release
2 material changes detected. Sign up free to read the summary.
10-K
Filed Apr 15, 2026
· Period ending Dec 31, 2025
revenue $57.0M, net income -$36.1M. Revenue falls 6% as MVNO collapses 69%; equity swings to $(15.4)M deficit on cash burn
5 material changes detected. Sign up free to read the summary.
8-K
Filed Mar 24, 2026
· Period ending Mar 18, 2026
Red flag
SurgePays receives dual Nasdaq deficiency notices for market value and bid price violations
4 material changes detected. Sign up free to read the summary.
10-Q
Filed Nov 12, 2025
· Period ending Sep 30, 2025
Summary not yet generated.
10-Q
Filed May 13, 2025
· Period ending Mar 31, 2025
Summary not yet generated.
10-K
Filed Mar 25, 2025
· Period ending Dec 31, 2024
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 19, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statements of Operations
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Revenues | 16,204,821 | 11,518,166 | 32,188,804 | 22,095,596 |
| Costs and expenses | ||||
| Cost of revenues | 16,629,992 | 14,172,832 | 40,311,533 | 27,692,607 |
| General and administrative expenses | 4,634,054 | 4,155,843 | 8,137,066 | 8,793,401 |
| Total costs and expenses | 21,264,046 | 18,328,675 | 48,448,599 | 36,486,008 |
| Gain on contract liability settlement | (8,511,672) | - | (8,511,672) | - |
| Income (loss) from operations | 3,452,447 | (6,810,509) | (7,748,123) | (14,390,412) |
| Other income (expense) | ||||
| Interest expense (including amortization of debt discount) | (1,026,341) | (279,306) | (1,907,348) | (398,740) |
| Loss on present value measurement of long-term accounts receivable | (415,067) | - | (415,067) | - |
| Accretion of discount on accounts receivable | 132,727 | - | 132,727 | - |
| Other income | 20,290 | - | 20,290 | 6,785 |
| Interest income | - | 7,008 | - | 64,267 |
| Derivative Expense | (1,168,511) | - | (1,168,511) | - |
| Change in fair value of derivative liabilities | 292,577 | - | 323,120 | - |
| Total other income (expense) net | (2,164,325) | (272,298) | (3,014,789) | (327,688) |
| Net income (loss) before provision for income taxes | 1,288,122 | (7,082,807) | (10,762,912) | (14,718,100) |
| Provision for income tax benefit (expense) | - | - | - | - |
| Net loss including non-controlling interest | 1,288,122 | (7,082,807) | (10,762,912) | (14,718,100) |
| Non-controlling interest | (227) | (209) | (378) | (418) |
| Net income (loss) available to common stockholders | 1,288,349 | (7,082,598) | (10,762,534) | (14,717,682) |
| Income (loss) per share - attributable to common stockholders | ||||
| Basic | 0.05 | (0.36) | (0.43) | (0.74) |
| Diluted | 0.05 | (0.36) | (0.43) | (0.74) |
| Weighted average number of shares outstanding - attributable to common stockholders | ||||
| Basic | 25,921,696 | 19,889,442 | 24,818,862 | 19,978,690 |
| Diluted | 25,921,696 | 19,889,442 | 24,818,862 | 19,978,690 |
Consolidated Balance Sheets
| Description | June 30, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current Assets | ||
| Cash and cash equivalents | 1,954,235 | 1,731,400 |
| Restricted cash accounts receivable factoring facility | 425,049 | 281,811 |
| Accounts receivable net | 1,828,586 | 4,045,162 |
| Inventory | 253,858 | 339,570 |
| Prepaids and other | 396,367 | 581,823 |
| Total Current Assets | 4,858,095 | 6,979,766 |
| Property and equipment net | 349,834 | 403,517 |
| Other Assets | ||
| Long-term accounts receivable net | 3,331,221 | - |
| Intangibles net | 492,399 | 819,153 |
| Operating lease right of use asset - net | 206,891 | 313,410 |
| Total Other Assets | 4,030,511 | 1,132,563 |
| Total Assets | 9,238,440 | 8,515,846 |
| Liabilities and Stockholders’ Deficit | ||
| Current Liabilities | ||
| Accounts payable and accrued expenses | 10,142,634 | 10,219,011 |
| Accounts payable and accrued expenses related party | 835,724 | 117,546 |
| Operating lease liability | 212,314 | 219,997 |
| Notes payable SBA government | 17,424 | 11,407 |
| Notes payable | 2,245,324 | 1,834,008 |
| Note payable related party | 1,730,796 | 2,730,796 |
| Convertible notes payable net | 9,869,374 | 3,068,878 |
| Derivative liabilities | 1,107,421 | - |
| Total Current Liabilities | 26,161,011 | 18,201,643 |
| Long Term Liabilities | ||
| Notes payable SBA government | 435,862 | 446,927 |
| Operating lease liability | - | 99,235 |
| Convertible notes payable net | 3,390,992 | 5,170,860 |
| Total Long Term Liabilities | 3,826,854 | 5,717,022 |
| Total Liabilities | 29,987,865 | 23,918,665 |
| Stockholders’ Deficit | ||
| Common stock, $0.001 par value, 500,000,000 shares authorized 27,207,618 and 21,847,927 shares issued and 26,511,665 and 21,151,974 shares outstanding, at June 30, 2026 and December 31, 2025, respectively | 27,211 | 21,852 |
| Additional paid-in capital | 88,657,683 | 83,246,736 |
| Treasury stock at cost (695,953 and 695,953 shares, respectively) | (1,631,966) | (1,631,966) |
| Accumulated deficit | (107,746,831) | (96,984,297) |
| Stockholders’ deficit | (20,693,903) | (15,347,675) |
| Non-controlling interest | (55,522) | (55,144) |
| Total Stockholders’ Deficit | (20,749,425) | (15,402,819) |
| Total Liabilities and Stockholders’ Deficit | 9,238,440 | 8,515,846 |
Consolidated Statements of Cash Flows
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Operating activities | ||
| Net loss including non-controlling interest | (10,762,912) | (14,718,100) |
| Adjustments to reconcile net loss to net cash used in operations | ||
| Depreciation and amortization | 380,437 | 479,689 |
| Amortization of right-of-use assets | 106,519 | 123,556 |
| Amortization of debt discount/debt issue costs | 930,509 | 66,887 |
| Stock issued for services | 843,935 | - |
| Stock issued for services related party | 657,900 | - |
| Recognition of stock based compensation related parties | - | 310,238 |
| Recognition of share based compensation options | 15,574 | - |
| Recognition of share based compensation options - related party | 110,208 | - |
| Change in fair value of derivative liabilities | (323,120) | - |
| Derivative expense | 1,168,511 | |
| Accretion of discount on accounts receivable | (132,727) | - |
| Gain on contract liability settlement | (8,511,672) | - |
| Loss on present value measurement of long-term accounts receivable | 415,067 | - |
| Changes in operating assets and liabilities | ||
| (Increase) decrease in | ||
| Accounts receivable | (1,396,985) | 319,496 |
| Inventory | 85,712 | (629,452) |
| Prepaids and other | 185,456 | 99,957 |
| Increase (decrease) in | ||
| Accounts payable and accrued expenses | 8,435,296 | 1,179,207 |
| Accounts payable and accrued expenses related party | 718,178 | (192,845) |
| Operating lease liability | (106,918) | (121,052) |
| Net cash used in operating activities | (7,181,032) | (13,082,419) |
| Investing activities | ||
| Purchase of leasehold improvements | - | (18,590) |
| Net cash used in investing activities | - | (18,590) |
| Financing activities | ||
| Proceeds from common stock issued for cash | 2,514,375 | - |
| Cash paid as direct offering costs common stock | (375,000) | - |
| Proceeds from issuance of notes payable | 954,272 | - |
| Repayments of notes payable | (585,994) | - |
| Proceeds from issuance of convertible notes payable | 5,070,000 | 6,000,000 |
| Cash paid as direct offering costs convertibles note payable | (25,500) | (595,000) |
| Repayments of loans related party | - | (684,419) |
| Repayments on notes payable SBA government | (5,048) | (5,512) |
| Treasury shares repurchased (share buy-backs) | - | - |
| Net cash provided by financing activities | 7,547,105 | 4,715,069 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 366,073 | (8,385,940) |
| Cash, cash equivalents and restricted cash beginning of period | 2,013,211 | 12,790,389 |
| Cash, cash equivalents and restricted cash end of period | 2,379,284 | 4,404,449 |
| Cash and cash equivalents | 1,954,235 | 4,404,449 |
| Restricted cash accounts receivable factoring facility | 425,049 | - |
| Total cash, cash equivalents, and restricted cash | 2,379,284 | 4,404,449 |
| Supplemental disclosure of cash flow information | ||
| Cash paid for interest | 76,379 | 188,244 |
| Cash paid for income tax | - | - |
| Supplemental disclosure of non-cash investing and financing activities | ||
| Conversion of debt to common stock | 385,880 | - |
| Conversion of debt to common stock related party | 707,200 | - |
| Debt forgiveness related party | 292,800 | - |
| Debt discount convertible notes payable - original issue discount | 143,333 | - |
| Debt discount convertible notes payable - issuance of common stock | 54,828 | - |
| Debt discount convertible notes payable - stated interest | 117,067 | - |
| Debt discount convertible note payable - embedded conversion feature (derivative liabilities) | 176,510 | |
| Debt discount convertible note payable - issuance of warrants (derivative liabilities) | 294,125 | - |
| Reclassification of derivative liability to additional paid-in capital | 208,606 | - |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗